A Phase I Study of Safety and Tolerability of Acetazolamide With Temozolomide in Adults With Newly Diagnosed Malignant Glioma
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 21 Aug 2017
At a glance
- Drugs Acetazolamide (Primary) ; Temozolomide (Primary)
- Indications Glioma
- Focus Adverse reactions
- 15 Aug 2017 Planned initiation date changed from 1 Jul 2017 to 1 Dec 2017.
- 06 Mar 2017 Planned initiation date changed from 1 Feb 2017 to 1 Jul 2017.
- 10 Jan 2017 New trial record